Member
|
|
Join Date: Oct 2010
Location: Surrey, England
Posts: 107
|
|
Member
Join Date: Oct 2010
Location: Surrey, England
Posts: 107
|
caveat
[OBJECTIVE: This study was undertaken to investigate L-type calcium channel blockers of the dihydropyridine class for association with Parkinson disease (PD), because some of these drugs traverse the blood-brain barrier, are potentially neuroprotective, and have previously been evaluated for impact on PD risk.
I did notice when initially googling it, that it was used to treat alcohol dependency, but I didn't stop drinking whilst taking it
|